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Running title: status of GM rice with health benefits  
 
 
Summary 
Micronutrient malnutrition, characterized by insufficient intake levels of vitamins and 
minerals, is a major public health problem that affects about 2 billion people worldwide. In 
order to reduce the burden of this ‘hidden hunger’, biofortification is more and more 
advocated as an alternative to the current micronutrient interventions. Through the 
enhancement of the micronutrient level of staple crops, it could address micronutrient 
malnutrition where the need is highest. Because staple crops are characterized by low 
micronutrient concentrations, genetic breeding techniques are often applied to increase 
specific vitamin levels, such as folate and pro-vitamin A. This study sheds a light on the 
global status of micronutrient malnutrition, biofortification and GM biofortified rice as both a 
GM food product with health benefits and a micronutrient intervention. Thereby, key 
consumer preference studies and cost-effectiveness analyses on Folate Biofortified Rice and 
Golden Rice are presented. Support is found for GM biofortified rice as a well-accepted GM 
food crop and a highly cost-effective health intervention. 
 
Key words: burden of disease; cost-effectiveness; rice biofortification; Folate Biofortified 
Rice; GM rice with health benefits; Golden Rice; micronutrient malnutrition; willingness-to-
pay. 
 
Abbreviations: DALY, disability-adjusted life year; GBD, Global Burden of Disease; GM, 
genetically modified. 
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I. Introduction 
 
Within the scope of crop improvement, biofortification of rice is more and more advocated as 
a tool to improve human nutrition. By enhancing the micronutrient level of the worlds’ most 
consumed staple crop, micronutrient malnutrition could be addressed where the need is 
highest. As rice varieties are mainly characterized by a low vitamin and mineral content, 
agricultural biotechnology is applied to increase specific micronutrient levels in rice, such as 
folate and pro-vitamin A (beta-carotene). This chapter describes the history and trends in 
biofortification and GM rice with health benefits in particular. In spite of the potential 
consumer benefits of this new generation of GM crops, the use of biotechnology in food 
products remains controversial. As none of these crops are available at the marketplace, they 
were subject of various ex-ante evaluation studies in order to examine the consumer demand, 
the potential health benefits and the cost-effectiveness of their introduction. By reviewing the 
current state-of-the-art, this study sheds a light on the potential of GM biofortified rice as both 
a GM food product with health benefits and an alternative policy intervention to tackle 
micronutrient deficiencies. 
As a starting point, the global burden of micronutrient malnutrition and the main 
micronutrient deficiencies is described (section II). In the following two sections, (GM) 
biofortification is described within the framework of health interventions to address 
micronutrient malnutrition (section III) and within the scope of agricultural crop improvement 
(section IV). Next, the global status of the development and commercialization of (GM) 
biofortified crops and GM rice (section V) as well as GM biofortified rice (section VI) is 
presented. While the section IV looks at the amount of published research on GM food, GM 
rice, biofortification and Golden Rice, section VIII and IX summarize the key research 
findings on the consumer preferences for, and the potential cost-effectiveness of GM 
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biofortified rice. These two research topics are crucial to ex-ante evaluate micronutrient 
interventions and GM foods. Finally, some key challenges (section X) and conclusions are 
formulated (section XI).  
 
 
II. What is at stake? The global burden of micronutrient malnutrition 
 
Micronutrient malnutrition
a1
 is defined by a chronic lack of micronutrients, i.e. essential 
vitamins and minerals that are needed in small quantities, and has a large impact on global 
health and (indirectly) hinders social and economic prosperity, e.g. through productivity 
losses, cognitive impairment and soaring health care costs
2, 3
. Malnutrition is considered one 
of the principal causes of morbidity and mortality among the poor
4
. 
Most people are not aware of their lack of micronutrients, due to the subclinical character of 
such deficiencies, and because the underlying causes and health functions of different 
micronutrients are neglected, poorly addressed, or still undiscovered. Therefore, this form of 
malnutrition is often referred to as the ‘hidden hunger’. Insufficient intake of micronutrients 
reflects a lack of dietary quality and especially strikes poor people living in rural, less 
developed areas, because these populations are largely dependent on staple crops (e.g. rice, 
maize and wheat), which are known to contain little micronutrients
2-5
. As a consequence, 
multiple micronutrient deficiency is the rule rather than the exception. Half of malnourished 
children, for instance, are deficient on several vital micronutrients
5
. 
 
                                                          
aThere is a clear difference between under- and malnutrition in that the former is a specific type of the latter. Whereas undernutrition refers to an inadequate 
intake of specific nutrients, malnutrition covers both under and over-nutrition, such as obesity but also micronutrient deficiency. In the scope of micronutrient 
malnutrition, “malnutrition” generally refers to undernutrition and, thus, micronutrient deficiencies. Therefore, this paper will use the term ‘micronutrient 
malnutrition’ to define all vitamin and mineral deficiencies. 
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Despite an increasing number of local and global programs to control micronutrient 
malnutrition, especially the main micronutrient deficiencies (Vitamin A, iodine, zinc and 
iron)
6
, it remains a major public health problem, in particular for children and (pregnant) 
women. According to global estimates of micronutrient malnutrition, nearly two billion 
people fail to achieve the recommended nutrient intake levels, mainly populations from low-
income countries
2
. As a consequence, an annual number of 10.3 billion US$ is still required to 
successfully fight the global burden of malnutrition, of which at least 1.5 billion US$ is 
needed to adequately combat micronutrient deficiencies
7
. Its magnitude differs when looking 
at specific micronutrient deficiencies and different data sources. The number of people with 
insufficient vitamin A intake, for example, varies between 140
8
, 190
9
 and 254 million
8, 10
. 
Iodine and zinc deficiency figures show that a total estimate of nearly 2 billion people is at 
risk
3, 11, 12
. Iron deficiency is another widespread type of micronutrient malnutrition, with 1.7 
billion people below the recommended intake levels
3, 11
. However, the public health 
significance of a micronutrient deficiency must be evaluated by looking beyond its 
prevalence, i.e. by estimating its health impacts. 
 
Table 1 lists some key figures regarding the devastating health and socio-economic impact of 
global micronutrient malnutrition. Its large importance is underpinned by its share in the 
global burden of disease (GBD). Together, vitamin A, iron, zinc and iodine deficiencies 
account for 4 % of the GBD in 2004. Regarding regional malnutrition, Southeast Asia is 
found to be the most problematic region, followed by Africa
13
. However, not all micronutrient 
deficiencies are included in the current burden analyses of the World Health Organization 
(WHO), among which folate deficiency. Rough estimations of the global burden of this type 
of vitamin deficiency, i.e. 4.8 million DALYs per year
14
, show that the contribution of 
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micronutrient malnutrition to the GBD is underestimated. According to the Micronutrient 
Initiative
15
, the total share in the GBD is expected to be around 10 %.  
Currently, public health programs are primarily targeted towards vitamin A, iodine, zinc and 
iron deficiency
7, 16, 17
, which are perceived as the four most important types of micronutrient 
malnutrition. Because children below 5 years mainly suffer from such deficiencies, it is not 
surprising that the nutritional targets of the Millennium Development Goals (MDG)
18
 and the 
nutritional challenge of the 2008 Copenhagen Consensus
19
 focus on this age group. In the 
framework of MDG 1 (eradicate extreme poverty and hunger), for instance, the United 
Nations strives to halve the prevalence of underweight children, i.e. one of the proxy 
indicators of poor nutrition, between 1990 and 2015
20, 21
. Furthermore, malnutrition also 
needs to be addressed in order to reduce child mortality (MDG 4), maternal health (MDG 5) 
and, indirectly, other major diseases (MDG 6), and to help achieve the goals on education 
(MDG 2) and gender equality (MDG 3)
11
.  
 
[Insert Table 1 here] 
 
 
III. GM biofortification as a novel micronutrient intervention 
 
There are currently four main strategies or (potential) policy interventions to address 
micronutrient malnutrition or particular vitamin or mineral deficiencies: pharmaceutical 
supplementation, food fortification, dietary diversification and biofortification (see Table 2).  
Pharmaceutical supplementation refers to micronutrient programs that distribute (multi-) 
micronutrient supplements for free or which promote the use of supplements. Key 
supplementation programs are based upon iron, zinc, vitamin A and/or folic acid 
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supplementation. The latter aims to reduce folate deficiency through increased consumption 
of folic acid, i.e. the synthetic form of folate. Industrial fortification refers to the insertion of 
micronutrients in staple crops, like rice and wheat, which takes place during flour milling. 
Dietary diversification is considered the most sustainable intervention and is targeted towards 
an increased intake of micronutrient-rich foods through nutrition education, promotion of 
diverse diets, improved access to locally produced foods rich in vital micronutrients. 
Although one could opt to address a particular micronutrient intervention through diversifying 
food habits, such as the promotion of green vegetables and citrus fruits to elevate folate intake 
levels, the ultimate goal of diversification strategies is usually to improve the dietary habits as 
whole, which encompasses a multi-micronutrient approach. 
 
Biofortification is considered a novel strategy to combat the ‘hidden hunger’, by which the 
nutritional content of staple crops is enhanced. By sharing the advantages of fortification (e.g. 
wide coverage) and addressing the limitations of supplementation (e.g. short term strategy, 
limited coverage, compliance of taking pills), it is intended to be a pro-rural and pro-poor 
health intervention (see Table 2). According to Welch
35
, agricultural approaches are a 
prerequisite to sustainably control micronutrient malnutrition. Biofortification is considered 
an agriculture/food based approach as it uses the regular food chain and goes beyond 
fortification, because the crops are fortifying themselves
36, 37
. This general definition of 
biofortification does not include agronomic biofortification, by which mineral contents are 
enhanced through the application of fertilizers
38
. Other biofortification strategies focus on the 
factors that increase the bioavailability of micronutrients rather than enhancing the production 
of micronutrients
39
. It is also important to note that also non-staple crops could be biofortified. 
A more exhaustive overview of biofortified staple and non-staple products, including 
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strawberries (vitamin C), maize and canola (vitamin E), potatoes and mustard (beta-carotene), 
carrots (calcium), lettuce (iron) is available in Hirschi
40
 and Johns and Eyzaguirre
37
. 
 
Contrary to dietary diversification and supplementation, biofortification uses staple crops as 
its food vehicle, by which behavioral changes are unlikely to be required. As a consequence, 
biofortification is self-targeting: as poor malnourished people mainly rely on staple crops, the 
groups at risk that need to benefit the most from the biofortified crops are addressed
41
. In that 
way, biofortification can be a complementary policy intervention by fighting micronutrient 
malnutrition where other interventions fail to do so. First of all, unlike food fortification or 
pharmaceutical supplementation, biofortification does not rely on an (centralized) industrial 
food processing sector or accessible public health infrastructures. Although food fortification 
is often promoted as the primary option to reduce micronutrient malnutrition
42
, the key target 
group of micronutrient interventions (i.e. poor, rural populations) rarely consumes processed 
foods suitable for fortification
43
. In addition, supplementation programs are often less 
successful on the long term
44, 45
. For example, folic acid supplementation programs in 
China
46
, Europe
47-49
 and the United States
50
 were not sustainable once the program finished, 
partly due to poor compliance and obedience to take folic acid supplements (correctly)
51
. 
Second, given the technical and practical difficulties it will be hard to successfully implement 
fortified rice, like folic acid fortified rice
52
, in developing malnourished regions. Third, 
biofortification uses staple crops as its food vehicle and, therefore, can easily target the 
micronutrient deficient subgroups, without the need to administer pills or to promote the 
consumption of, generally more expensive, micronutrient-rich foods. Furthermore, industrial 
fortified foods and supplements are often only available in cities and hence cannot reach the 
poor rural populations. Fourth, possible negative side effects of food fortification, such as the 
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relation between folic acid fortification and masking Vitamin B12 deficiency or an increased 
risk of colorectal cancer, are less likely to occur with biofortification
53
. 
Due to the relatively low costs of biofortified crops, e.g. a one-time investment in R&D and 
the ability of farmers to reproduce their biofortified crop seeds, the cost-effectiveness of 
biofortified crops is often argued as one of the main arguments in favor of this strategy
36, 41, 54
. 
Whereas supplementation and fortification were the two key strategies to control 
micronutrient malnutrition in the past, biofortification receives more and more attention
2
. 
During the 2008 Copenhagen Consensus, where a panel of economists evaluated the top 
priorities to counter the world biggest challenges, biofortification was placed fifth
55
. 
 
Notwithstanding the large potential of single biofortified crops, one could argue that the large 
prevalence of multiple micronutrient deficiencies and the generally low micronutrient 
contents of rice and other staple crops require a combined biofortification strategy. In other 
words, there is a need to increase the intake of different micronutrients simultaneously 
through nutritionally complete crops. This is where multi-biofortification enters the public 
health debate. By enhancing different vitamins and minerals, through conventional or 
transgenic technologies, multi-biofortification could address micronutrient malnutrition more 
adequately and efficiently.  
In spite of several ongoing initiatives that attempt to develop multi-biofortified crops, 
especially those that were or are supported by the Bill & Melinda Gates Foundation under the 
Grand Challenges in Global Health Initiative, such as rice, sorghum, cassava and banana
56, 57
, 
evidence of a developed staple crop which stacks different nutrient traits is scarce. Recently, 
Naqvi et al.
58
 published the development of the first transgenic multi-biofortified crop, i.e. 
maize enriched with vitamin A, vitamin C and folate. Such gene stacking applications are 
already successfully applied and commercialized in the field of 1
st
 generation GM crops, 
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mainly crops that combine herbicide-tolerance and insect-resistance traits
59
. However, these 
technologies are still in the research pipeline, and little is known about their potential from a 
public health, an agricultural and an economics perspective. 
Targeting different micronutrient deficiencies at once is a strategy which is also found in 
other policy interventions, such as pharmaceutical multi-vitamin supplementation, e.g. iron-
folic acid multivitamin pills in India
60
 and other Asian countries
61
, multi-micronutrient food 
fortification, e.g. fortifying grain with folic acid, Vitamin B12 and several minerals
62
, and 
dietary diversification. 
 
Table 2 presents an overview of the key characteristics of the different micronutrient 
interventions. The common objective of these interventions is primary prevention, i.e. 
tackling micronutrient deficiencies as a risk factor of various diseases. While the two 
‘industry’ based interventions, supplementation and food fortification, aim to reduce 
micronutrient malnutrition through the enhancement of micronutrient levels in, respectively, 
supplements (pharmaceutical industry) and staple crops (milling sector), the objective of 
dietary diversification and biofortification is to increase the natural micronutrient levels. 
 
[Insert Table 2 here] 
 
 
IV. GM biofortification as a novel approach of crop improvement 
 
Before biofortification, efforts to improve crop content were mainly focusing on agronomic 
traits, such as increasing yield potential and productivity, drought resistance and pest 
resistance, which primarily benefit the farmer. Table 3 gives an overview of the main stages 
of crop improvement. As these developments in agriculture were based on two different 
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techniques, conventional versus transgenic technology, they marked the Green and Gene 
Revolution, respectively
36, 39, 63, 64
. The Green Revolution refers to a broad public sector led 
transformation of agricultural sectors in developing countries, mainly between the 1960s and 
1980s, which focused on developing high yielding staple crop varieties (wheat, rice), 
promoting the utilization of hybridized seeds, pesticides (insecticides) and fertilizers, and 
providing agricultural extension in order to reduce food shortages and hunger and stimulate 
overall development
65
. Nobel Peace Prize winner Norman Borlaug is seen as the founding 
father of this breakthrough in crop development. In the last decennium of the 20
th
 century, a 
novel private led agricultural revolution took place, the Gene (biotech) Revolution, which 
built upon the previous revolution by implementing GM technology in agriculture to improve 
productivity and, thereby, reduce hunger.  
 
The history of biofortification followed a similar approach, starting with the introduction of 
conventionally bred nutritionally enriched products in the 2000s (conventional 
biofortification), and now making progress to commercialize the ‘gene revolution’ in 
biofortification through private-public partnerships (GM biofortification). What the Green and 
Gene revolutions meant for agricultural productivity and hunger (food quantity), these 
biofortification trend hopes to achieve in the field of malnutrition and the ‘hidden hunger’ 
(food quality). In this respect, one can refer to a shift from producer, input or quantity traits to 
consumer, output or quality traits
66
. Although an increased micronutrient content is certainly 
one of the most advanced improved quality trait in crops, also other quality traits can be 
addressed, like the elimination of allergens, improved taste, texture or other sensory 
characteristics, and the prolongation of shelf life. Nevertheless, ‘GM biofortified crops’ and 
‘GM crops with health benefits’ are treated as synonyms in this study.  
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Within the scope of crop improvement through GM technology, broadly two product 
categories can be distinguished: 1
st
 versus 2
nd
 generation GM products. GM biofortified crops 
belong to the 2
nd
 generation of GM crops, which are primarily designed to benefit the 
consumer by improving quality traits, among which nutritional properties. The application of 
GM technology to develop nutrient-dense crops is sometimes referred to as ‘nutritional 
genomics’67. These developments followed the Gene Revolution and its 1st generation of GM 
products, which dealt with enhanced agronomic traits, such as insect resistance and herbicide 
tolerance. In other words, the evolution from first to second generation involves a shift from 
producer-friendly to consumer-friendly genetic modification
68
. An overview of the consumer 
and farmer benefits of first and second generation GM food products is described in 
Toenniessen et al.
69
 and Lönnerdal
70
, respectively. 
Despite these ‘generation’ differences, future GM crops are more likely to combine improved 
traits from both the 1
st
 and 2
nd
 generation.  In order to make GM biofortified crops attractive 
to consumers as well as producers, both the health and agronomic benefits have to be 
addressed. While farmers will be more in favor of adopting biofortified crops when the yield 
characteristics are beneficial
12, 71
, multi-biofortification will be more likely accepted and 
consumed by consumers. In this way, stacking refers to the improvement of different output 
and input traits.  
Next to this tendency, some people argue the need for an ‘evergreen’ revolution, which 
combines the economic viability of the Green and/or Gene revolution with a need for 
ecological sustainability, while improving awareness and knowledge
72
. There is also a third 
generation of GM crops, where products are developed for industrial or pharmaceutical use. 
Among the examples are vaccines or biodegradable plastics
73
. 
 
[Insert Table 3 here] 
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V. The global status of (GM) biofortification and GM rice  
 
Biofortification research was accelerated when the international, multidisciplinary 
HarvestPlus (Biofortification Challenge) program was launched in 2004 by the Consultative 
Group on International Agricultural Research (CGIAR) and the International Food Policy 
Research Institute (IFPRI)
65, 74
. It became the key project in development and dissemination 
of biofortified crops, with an emphasis on iron, zinc and vitamin A deficiencies in Africa and 
Asia. Initially, only conventional biofortified crops were explored, until the development of 
Golden Rice as the first biofortified staple crop that was genetically engineered to tackle 
Vitamin A deficiency in 1999
75, 76
. This was the starting point of the humanitarian 
HarvestPlus supported Golden Rice project
77
.  
While Africa and Asia fall within the scope of HarvestPlus, AgroSalud coordinates the 
biofortification efforts in Latin America and the Caribbean (LAC), and aims to increase the 
iron and zinc content of beans, rice, maize, and sweet potatoes, and develops yellow maize 
and orange-fleshed sweet potato with higher beta-carotene contents
78, 79
. Between 2007 and 
2010, AgroSalud introduced 42 biofortified cultivars in 13 LAC countries
80
. Depending on 
each country’s policy, the seeds are sold at full or subsidized price, or given for free to 
farmers. 
 
The global status of biofortified staple crops, developed and/or released by HarvestPlus or 
AgroSalud, is shown in Table 4. To date, only conventionally bred biofortified staple crops, 
such as vitamin A enriched sweet potatoes, iron biofortified beans and rice, and maize with a 
higher vitamin B3 content, are released. Also the future releases will be mainly dominated by 
14 
 
conventional breeding techniques, such as vitamin A biofortified cassava and maize, and 
wheat, rice and beans with higher zinc and iron levels. However, the progress of Golden Rice 
or vitamin A biofortified rice shows that transgenic biofortified staple crops are in the pipeline 
of approval. Also other crops, like banana, barley, cowpeas, groundnuts, lentils, pigeon peas, 
potatoes and sorghum, are expected to become the subject of biofortification
36
. It is important 
to note that not all R&D efforts in the field of biofortification are presented. In China, for 
example, a conventional biofortified zinc enriched wheat crop (“Jingdong 8”) is 
commercialized, but at a very small-scale. Nevertheless, about 16 Chinese crop varieties/lines 
are developed, of which 4 have been approved for advanced testing (2011 figures).  
 
[Insert Table 4 here] 
 
The current status and future pipeline of GM biofortified rice, i.e. GM rice with health 
benefits, is described in Table 5 and Table 6, respectively. When looking at the approval of 
GM rice events, it is clear that only first generation GM rice crops, such as herbicide tolerant 
and insect resistant rice, are currently approved for food, feed and cultivation. There are eight 
different GM rice events listed. The insect resistant GM rice in Iran is the only event that has 
been commercially cultivated in the past, but is currently not authorized
84
. The  targeted GM 
rice traits are insect resistance, herbicide tolerance and antibiotic resistance. Apart from the 
Liberty Link rice crops, developed by Bayer Crop Science, all events are approved in only 
one country (Japan, China and Iran). GM Shanyou 63, as well as LLrice601, LLrice62 and the 
Iranian event are approved for food, feed as well as cultivation. None of these events are 
grown or commercialized for food or feed. In other words, GM rice is yet to be 
commercialized in the world. 
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Second generation GM rice crops, and GM biofortified rice in particular, are only present in 
the R&D pipeline. According to the study of Stein and Rodriguez
84
, it is expected that by 
2015 more or less than 15 GM events will be cultivated, among which also stacked traits. 
Especially the Chinese traits are expected to be commercialized in the near future, in line with 
the recent approval of Bt rice
85
. In the field of GM biofortification, only the vitamin A 
enriched Golden Rice (1
st
 and 2
nd
 variant) is currently in an advanced development stage.  
Since most of the GM rice product in the R&D pipeline are developed by Asian providers for 
direct use at the domestic market, the number of GM rice events that will be approved and 
commercialized in the future, are expected to be low. Today, only LLrice62 is submitted for 
approval in the European Union. Despite the positive evaluation of the European Food Safety 
Authority, this application is currently not moving forward to a decision in the European 
Commission, leading to a delay of the potential authorization (EFSA received the application 
dossier in August 2004). If this and other GM rice events would be approved and introduced 
only at the Asian marketplace, global trade problems are expected to occur due to the Low 
Level Presence thresholds for rice imports in the EU.  
 
[Insert Table 5 here] 
[Insert Table 6 here] 
 
 
VI. GM rice crop with health benefits: the case of rice biofortification 
 
In order to successfully tackle micronutrient malnutrition through GM biofortification, one 
should carefully select the food vehicle for biofortification. In principle, a staple crop like 
rice, wheat, corn or potato should be selected in order to reach the rural, poor populations who 
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need to increase their micronutrient intake levels the most. There are several reasons which 
underpin the focus on rice to reduce micronutrient malnutrition. Rice is not only the most 
consumed and produced product in the world. It is also known to have low micronutrient 
contents, such as folate and provitamin A. Furthermore, the selection of rice as the food 
vehicle for biofortification is in line with the technical considerations of fortification, i.e. 
using an inexpensive, country-wide staple crop, as postulated by the Asian Development 
Bank
17, 87
. 
In some cases, it is feasible to increase micronutrient concentrations in rice through 
conventional breeding techniques, similar to biofortified maize, wheat, beans, cassava
41
. This 
is, for example, true for zinc and iron levels in rice
88
. In other cases, however, the application 
of conventional plant breeding techniques to enhance the micronutrient content of rice is less 
(e.g. folate) or not possible (e.g. provitamin A). Even though there is a clear potential for 
conventional bred folate enriched rice, achieving similar folate improvements as in transgenic 
techniques will be difficult, because of the low folate levels in natural rice
89, 90
. Therefore, 
folate enriched rice in this study is seen as a transgenic biofortified staple crop or 2
nd
 
generation GM crop. 
Below, the focus will be mainly on two GM biofortified rice crops, namely Folate Biofortified 
Rice and provitamin A enriched ‘Golden Rice’. Three reasons can be cited for this choice. 
First of all, there are several studies in international peer-reviewed journals which report the 
reconstitution of the folate
79, 86, 88
 and carotenoid biosynthetic pathway
75, 91, 92
. Second, while 
rice with a higher folate content, developed by metabolic engineering, is currently the most 
advanced folate enriched staple crop
89, 93
, Golden Rice is the most advanced GM biofortified 
crop and will be most likely the first to be commercialized (An overview of the typical steps 
in the development process of transgenic biofortified crops, e.g. efficacy testing, elite event 
selection and trait integration, is available in Dubock
94
. We further refer to several biotech 
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studies for a detailed discussion on the technological issues regarding folate biofortification of 
food plants
89, 95
, including rice
81
, wheat
96
 and tomatoes
97
). Third, both GM crops were subject 
of various consumer studies on acceptance and willingness-to-pay, health impact analyses and 
cost-effectiveness studies. In addition, the link will be made with multi-biofortification. Here, 
multi-biofortification of rice is understood as rice enriched with folate, beta-carotene (pro-
vitamin A), zinc and iron, in line with De Steur et al.
26
. Although iron
98, 99
 and/or zinc
100, 101
 
may also be increased though transgenic approaches, and about 43 genes of five protein 
families are expected to be involved in rice
102
, they are not included in this study due to the 
lack of socio-economic studies on these GM biofortified rice crops. 
 
Table 7 describes the key characteristics of Folate Biofortified Rice and Golden Rice. Taking 
into account the biotechnology characteristics, such as the elevated levels of folate and 
provitamin A in rice, the post-harvest losses (e.g. cooking) and the bioavailability, i.e. of the 
absorption of folate or provitamin A - converted into vitamin A - in the human body, vitamin 
concentrations after GM biofortification of rice vary between 1.5 µg – 3.0 µg folate per g rice, 
and 1.0 µg – 6.5 µg provitamin A per g rice, depending on the impact scenario. These 
micronutrient levels are substantially higher than in regular rice varieties. In the case of Folate 
Biofortified Rice, the total folate intake level after biofortification is 40 times larger than 
without biofortification. The amount of GM biofortified rice needed in order to recover from 
folate and vitamin A deficiency depends on the current rice consumption patterns, and 
whether these patterns are still maintained when (partially) switching to GM biofortified rice, 
and on the current (dietary) vitamin intake. The table below demonstrates how much GM 
biofortified rice a consumer needs to consume in order to achieve the daily recommended 
nutrient intake level (RNI) of the target group. This refers to a theoretical scenario where a 
consumer does not consume any vitamins through its diet. In other words, these figures 
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represent the (GM biofortified) rice consumption threshold to avoid being micronutrient 
deficient in a situation where only rice could be consumed. In the current situation, i.e. 
without folate biofortification, a consumer should eat about 5 kg of rice per day in order to 
reach the RNI for folate, if he/she only depends on rice. When the same consumer eats Folate 
Biofortified Rice instead, he/she only needs 281 g (pessimistic) to 137 g rice (optimistic) to 
achieve adequate folate levels. In the case of Golden Rice, it is even not possible to consume 
vitamin A through a regular rice diet. The two biofortification scenarios demonstrate that 
between 500 g and 77 g (children under 5 years) and 800 g - 122 g golden rice (pregnant 
women) is daily needed to exceed the RNI for vitamin A. And even if the biofortified rice 
consumption should be below these theoretical thresholds, it should lead to positive health 
impacts, - although a full protection from the health outcomes of these micronutrient 
deficiencies is then impossible. Nevertheless, one could also argue that transgenic lines with a 
higher micronutrient content could be developed in order to tackle micronutrient deficiencies 
in regions with medium or low rice consumption. Storozhenko
81
, for example, reported 
transgenic rice lines with elevated folate levels up to 17 µg per g rice, as compared to an 
average of 12 µg folate per g rice. 
 
[Insert Table 7 here] 
 
The aforementioned GM biofortified crops are presented as examples of ‘single trait’ 
biofortification. However, a multi-biofortification approach might be more likely to occur in 
the future. Such biofortified crops with enhanced micronutrient concentrations can be 
developed in two ways. In the so-called ‘single insertion’ approach, the targeted micronutrient 
traits are stacked as one gene construct. A ‘backcrossing’ approach, where all traits are 
separately developed and combined through backcrossing
81, 93
, is expected to be more costly, 
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due to high regulatory and financial costs to approve all new events as single traits, as well as 
the time and financial costs required for the testing and approval of each event
111
. Moreover, 
micronutrient traits are mainly developed by different research institutes, which makes a 
single insertion approach the most realistic scenario.  
 
 
VII. Published research coverage on GM food, GM rice, biofortification and 
Golden Rice 
 
This section gives a brief overview of the number of publications (2000-2011) in four relevant 
research domains: GM food, GM rice, biofortification, and Golden Rice. Whereas GM food 
and (GM or conventional) biofortification are broad food research topics, the topics GM rice 
and particularly Golden Rice deal with research applied on a specific staple crop. In this way, 
this exercise aims to summarize the evolution of international peer-reviewed journal 
publications in these different, but closely related research fields and particularly in the 
domain of GM rice crops with health benefits. Golden Rice was selected as it is the GM 
biofortified crop that received most attention, both at research and policy level. 
This rudimentary, targeted trend analysis is based on a literature search in the electronic 
literature database Web of Knowledge. The database search used the following keywords in 
the topic field: GM food; GM rice; biofortification and Golden Rice. It is important to notice 
that the selection of publications is based on studies from various research disciplines, like 
biotechnology and genetic engineering (e.g. R&D), agriculture (e.g. impact analyses), politics 
(e.g. policy level analysis), marketing (e.g. consumer studies), economics (e.g. cost-
effectiveness assessment), and so on. Furthermore, some of the selected studies, for example, 
did not focus on Golden Rice alone but included it as a case-study, a benchmark exercise or 
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referred to, or built upon this application as a part of the study. Therefore, the extent to which 
these studies actually explore GM food or another topic (keyword) varies substantially, by 
which the total numbers should be interpreted with caution. Nevertheless, as this potential 
selection bias occurs in each database search, it is possible to benchmark the importance of 
these GM related fields in scientific literature. Stated differently, one should evaluate the 
trends, rather than the absolute figures. 
The results in Figure 1 show that the number of publications in all four research domains 
increased in the last decade. The total research coverage between 2000 and 2011 amounts, 
from small to large, Golden Rice (142), GM rice (362), biofortification (459) and GM food 
(1631). GM food research publications almost doubled since 2000. The other topics were still 
marginal in the beginning of this century. The publications on Golden Rice, i.e. vitamin A 
enriched GM rice, follows a similar trend as GM rice in general. Both research topics steadily 
increased since 2004. But what is more striking is the progression in biofortification research. 
While this topic was hardly addressed at the start of the targeted period, with only 3 
publications between 2000 and 2002, the number of publications progressively increased 
since 2004, rising to about 251 publications in 2009-2011. Together with the figures of 
biofortification and GM rice, this demonstrates the growing importance of GM crops with 
health benefits and GM biofortified rice in particular. 
 
[Insert Figure 1 here] 
 
 
VIII. Consumer preferences for GM biofortified rice 
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As none of the GM biofortified crops are currently approved for cultivation and consumption, 
it is crucial to determine ex-ante the potential demand for such novel crops. Within the large 
body of literature on biofortification and GM food/rice, there are several studies that aimed to 
determine consumers’ willingness-to-pay for GM biofortified rice. Given the direct health 
benefits associated with GM biofortification, due to the enhanced micronutrient content, these 
studies mainly aimed to assess the amount consumers are willing to pay more for nutritionally 
enriched rice. In Table 8, seven economic valuation studies on GM biofortified rice crops are 
presented. While the study of Li et al.
112
 focuses on GM biofortified rice in general, without 
making reference to a specific micronutrient trait, the other consumer studies examine either 
folate or provitamin A enriched ‘Golden’ Rice. Depending on the applied methodology, 
Chinese consumers are willing to pay a premium between 34 % (hypothetical method, i.e. 
contingent valuation)
113
 and 72 % (non-hypothetical method, i.e. experimental auctions) for 
Folate Biofortified Rice
114
. With respect to Golden Rice, willingness-to-pay values vary 
between 19.5 %
115
 (India) and 40.0 %
116
 (Philippines) in Asia. In the United States, premiums 
for Golden Rice are substantially lower, i.e. 16.0 % on average
117
. Besides the GM 
biofortified rice studies, other studies obtained economic valuations for conventional 
biofortified crops. The high consumer preferences for vitamin A enriched cassava in North-
East Brazil (60%-70%)
118
, for example, are partly due to the high prevalence rate of vitamin 
A deficiency in this region. Also De Groote et al.
119
 elicited valuations for a crop with a 
higher vitamin content, namely willingness-to-pay for biofortified corn. Their results showed 
that consumers in Kenya are prepared to pay 24 % more for corn if it would be enriched with 
provitamin A. Although these findings provide insight in the consumer preferences for GM 
biofortified rice, caution is needed when benchmarking these premiums, due to the study 
specific characteristics (e.g. the valuation method, the sample selection, the targeted product 
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and the selected trait). Nevertheless, when looking at the high premiums, these positive 
reactions support the high potential demand for GM biofortified crops.  
 
[Insert Table 8 here] 
 
 
IX. Potential cost-effectiveness of GM biofortified rice 
 
As GM biofortified rice is not only an innovative food crop, which is based on agricultural 
biotechnology, but also a potential alternative policy intervention to reduce the burden of 
micronutrient malnutrition, health impact and cost-effectiveness analyses are also considered 
a crucial aspect to adequately evaluate its socio-economic potential
120
. In Table 9 five key 
health impact studies are described, of which four also assessed the potential health impact. 
The Chinese regional health impact analysis of De Steur et al.
27
 is not included, as the study 
on multi-biofortification further builds upon their results by including a cost-effectiveness 
study on folate and three other micronutrient traits in rice (provitamin A, zinc and iron). For 
an overview of cost-effectiveness studies on other biofortified crops, see Meenakshi et al.
121
. 
The potential health benefits of folate, provitamin A and multi-biofortified rice are measured 
by their potential contribution to lower the current burden of micronutrient deficiencies. The 
results vary between 6 % and 20 % in the pessimistic scenario and 32 % and 60 % in the 
optimistic scenario. The cost-effectiveness is expressed by the cost (US$) to save a Disability-
Adjusted Life Year (DALY) that is initially lost due to the targeted micronutrient deficiency. 
When looking at the World Bank cost-effectiveness cut-off level for highly cost-effective 
health interventions
122
, i.e. 258 US$ per DALY saved in 2011
123
, all GM biofortified rice 
crops fall below this threshold. Due to the combined health impacts multi-biofortified rice, 
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and the associated cost reductions, the cost-effectiveness of this GM rice crop is substantially 
lower than the so-called single GM biofortified rice crops.  
Although these studies differ in its targeted trait and country, but also in the data assumptions, 
this table is not intended for comparison of different figures. Instead, one should interpret the 
evaluation of the introduction of the different GM biofortified rice crops as a whole. Taken 
together the health impact and cost-effectiveness figures, GM biofortified rice, regardless of 
the targeted trait or region, is considered a highly cost-effective intervention to combat 
micronutrient malnutrition.  
 
[Insert Table 9 here] 
 
 
X. Key challenges of the commercialization of GM biofortified rice 
 
Despite its large potential, GM biofortification has not been the magic bullet in the fight 
against micronutrient deficiencies. According to Hotz and McClaferty
124
 there are numerous, 
technical, practical, market oriented or other concerns that need be addressed to successfully 
achieve the goal of biofortifying staple crops. For instance, although some target 
micronutrients need to undergo bioconversion before the body can utilize them, a process that 
is not 100% effective e.g. pro-vitamin A  (beta-carotene) needs to be converted to vitamin A. 
Furthermore, although differences in appearance could be used to adequately position 
biofortified products in the market place
41
, several studies show that acceptance of GM crops 
will be compromised if they do not resemble the conventional products
125-127
. Rice 
fortification, for instance, may lead to an intensification of color, which negatively affected its 
acceptability in Thailand and Bangladesh
128
. With respect to Golden Rice, the visible 
differences between this GM biofortified rice crop and its regular counterpart could be a 
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constraint to consumer acceptance, because its yellow color may be linked with a longer shelf 
life and, thus, lower quality. Similarly, orange, pro-vitamin A biofortified maize is less 
preferred than unfortified white maize
129, 130
.  
Although scientific evidence is lacking, GM biofortification may also change sensory 
attributes, which could reduce consumers’ willingness to consume such micronutrient 
enriched crops. The aroma and taste of (conventional) pro-vitamin A enriched maize, for 
example, was negatively evaluated in Mozambique
130
. Other negative product attribute 
changes that might be associated with GM biofortification of rice, such as shelf life, duration 
and sensory quality of cooking, could also play a role and need to be further investigated
129
. 
For a discussion on key issues and challenges to advance towards a successful implementation 
of Folate Biofortified Rice and Golden Rice, we refer to De Steur et al.
120
 and the Bertebos 
foundation report
131
, respectively. 
 
 
XI. Conclusions 
 
GM biofortified rice as a specific GM crop with health benefits is more and more examined as 
an alternative policy intervention to combat micronutrient malnutrition. At the turn of the 
century, the first publications on biofortification and Golden Rice as the first GM biofortified 
crop appeared. From 2004 onwards, the amount of research in the field of GM food, GM rice 
and particularly biofortification drastically increased. When looking at consumer studies on 
GM biofortified rice, the findings show that consumers in target countries are willing to pay 
for improved micronutrient contents in rice. The high premiums for both Folate Biofortified 
Rice and Golden Rice, indicate that there is a consumer market for GM rice crops with health 
benefits. The high cost-effectiveness of single (folate, provitamin A) and multi-biofortified 
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rice (folate, provitamin A, zinc and iron) further support the potential of GM biofortification 
to tackle a major public health problem like vitamin A and folate deficiency.  
GM biofortification of rice comes at a time when the debate is rife on the adoption of GM 
food in many countries in the developing world. Despite its additional health benefits, future 
research is needed to adequately and sustainably introduce GM biofortified rice at the market 
place. Even though pro-vitamin A enriched rice is on the verge of being released, it is evident 
that it will only serve regions where rice is a staple. Moreover, although GM biofortification 
(of rice) is technically “cost effective”, scientifically underpinned communication and 
promotion actions are needed to further convince governments and public health agencies of 
its potential in the developing world.  
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Tables 
 
Table 1. Key figures of the estimated global impact of micronutrient malnutrition, estimated burden of 
disease in million DALYs lost and as a percentage of the Global Burden of Disease, per main micronutrient 
deficiency 
Type of micronutrient deficiency Estimated burden of diseasef 
 2000g 2004 
 mi. DALYs 
lost 
%  
of GBD 
mi. DALYs 
lost 
%  
of GBD 
Micronutrient malnutrition (MM) 93.2 6.3 60.9 4.0 
 2 million children may die each year due to MMa     
 MM is the world's leading cause of mental impairmentb     
 MM is responsible for productivity losses of up to 2% of GDPb     
Vitamin A deficiency (VAD)  26.6h 1.8h 22.1l 1.5l 
 VAD-related night-blindness and blindness are affecting 5 million  
and 350.000 children, respectivelyc 
    
 VAD is responsible for 0.5 to 1 million child deaths each yearb,c     
Iron deficiency (ID)  35.1d 2.4d 19.7l 1.3l 
 ID affects the health and energy of 40% (women)a and the mental 
development of 40-60 % (children)b,d in developing countries. 
    
 ID is estimated to result in the annual death of 841.000 personsg,  
of which 50.000 young women in pregnancy and child birthb 
    
Zinc deficiency (ZD) 28.0e 1.9e 15.6l 1.0l 
 About 800 000 child deaths per year are related to ZDe     
 ZD is associated with approximately 176.000 diarrhea deaths,  
406.000 pneumonia deaths and 207. 000 malaria deaths each yeare 
    
Iodine deficiency (IOD)  3.5i 0.2i 3.5l 0.2l 
 Each year, IOD leads to an estimated number of 18-20 million  
mentally impaired babies are borna,b 
    
 IOD is estimated to lower the intellectual capacity of developing  
countries by 10 to 15 percentage pointsb 
    
Folate deficiency (FD) NDj NDj 
 FD is estimated to result in approximately 200.000 severe birth  
defects every yearb 
    
 About 1 in 10 adult deaths from heart diseases are attributed to FDb.     
 
DALY, Disability-Adjusted Life Year; FD, folate deficiency; GBD, Global Burden of Disease; ID, iron deficiency; IOD, 
iodine deficiency; MM, micronutrient malnutrition; ND, no data available; VAD, vitamin A deficiency; ZD, zinc 
deficiency  
Note: Figures on the global burden of all malnutrition are not presented. According to the FAO report on the state of 
food insecurity in the world3, malnutrition in the developing world leads to a total loss of 220 million (childhood and 
maternal undernutrition) to 430 million (including nutrition-related risk factors) DALYs. 
a Micronutrient Initiative15; b UNICEF5, 22; c Micronutrient Initiative report2; d Stoltzfus et al.23; e Caulfield and Black24; f 
More information on the application of DALYs and the DALY-approach, see De Steur et al.25-27; g The burden of 
different micronutrient deficiencies in 2000 are based on the Comparative Risk Factor Assessment (CRA) of the 
WHO13. The data are available at the WHO website28; h Rice et al.10; i WHO World Health Report 29; j The global folate 
deficiency prevalence is not established, as Kennedy et al.30 demonstrate, but is expected not to be a marginal 
phenomenon 31. Based on the most important outcome of FD, i.e. Neural-Tube Defects, calculations of De Steur et al.14 
reveal a global burden of FD of at least 4.8 million DALYs, which is significantly more than the rough 2.3 million 
estimation of Blencowe et al.32. However, this is still an underestimation, as other functional outcomes are not 
included; lWHO report on Global Health Risks33. The statistics from the report are available at the WHO website34.   
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Table 2. Characteristics of the key interventions to reduce micronutrient deficiencies   
 Industry based interventions  Natural micronutrient based interventions 
 Supplementation  Food fortification  Dietary 
diversification  
(GM) Biofortification  
Micronutrient 
dose  
RNI dose  Micronutrient  enriched 
staple crops   
Micronutrient-rich  
foods  
Micronutrient enriched 
staple crops  
Potential 
coverage  
People taking  
supplements  
Consumers of 
processed  
staple crops  
Consumers taking 
part in promotion/  
education program  
Consumers  
of (GM) staple crops   
Target group  (Rural) risk regions  (Urban) populations  Rural risk regions  (Poor) populations  
Behavioral 
changes  
Taking pills 
(correctly)  
None  Changing  
dietary habits  
None, unless a 
product attribute  
is changed  
Funding  Continuous  Continuous Long-term One-time R&D, 
continuous labeling & 
maintenance costs 
Funding source Public Public or private Public Public 
Development  Pharmaceutical 
industry 
Food processing 
industry 
Government Research institutes 
Distribution  Health workers/ 
system 
Food supply chain 
(marketing channels) 
Health, extension & 
education system 
Seed distribution 
system 
Note: Own compilation, based on Stein et al. 
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GM, Genetically Modified; R&D, Research & Development; RNI, recommended nutrient intake 
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Table 3. The main stages of crop improvement 
 Crop improvement 
 Agronomic traits Quality traits 
 Green revolution Gene revolution Conventional 
biofortification 
GM biofortification 
Breeding technique Conventional  GM technology Conventional  GM technology 
Timing  60s-80s 90s - … 00s - … NC - … 
Key beneficiary Producer (input) Consumer (output) 
Key objective 
Long term objective 
Yield improvement 
Hunger reduction 
Health improvement 
Hidden hunger reduction 
GM crop generation / 1st generation / 2nd generation 
Examples herbicide tolerance, drought tolerance,  pest 
resistance, and/or virus resistance 
enhanced vitamin and/or  
mineral contents 
NC, not commercialized; GM, Genetic Modification 
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Table 4. A brief overview of the currently biofortified products in the world, developed by HarvestPlus or 
AgroSalud, according to the improved micronutrient, applied technology, target area of first release and 
(expected) release year. 
Micronutrient Product 
Applied  
technology 
Target Areac 
Release year 
  (# cultivars released) 
Expected  
release year 
Vitamin A 
(Beta-carotene)a 
Cassava CB DR Congo and Nigeria  2011-2012 
Maize CB Zambia  2012 
Sweet Potato      CB Uganda and Mozambique 2007  
Brazil, Cuba, Dominican 
Republic, Haiti and Peru 
2009-2010 (8)  
Rice TB Philippines,  
Bangladesh, India 
 2012, 
2013, 2014e 
Iron Pearl Millet CB India  2012 
Rice CB Bolivia, Cuba and Panama 2009-2010 (8)  
Brazil, Colombia, Nicaragua  
and Dominican Republic 
 2011 
Bean CB Bolivia, Brazil, Cuba and 
Guatemala 
2008-2010 (5)  
Colombia, Costa Rica, El 
Salvador, Honduras and 
Nicaragua 
 2011 
Iron,  Zinc Wheat CB India and Pakistan  2013 
Bean CB DR Congo  
and Rwanda 
  2011-2012 
Rice CB India, Bangladesh  2013 
Vitamin B3 
(Niancin)b 
Maize CB Bolivia, Colombia, El Salvador, 
Guatemala, Haiti, Honduras, 
Mexico, Nicaragua and Panama 
2008-2010 (21) ND 
Folate  Rice TB Chinad  NDd 
 
ND, No data 
Source: Own compilation, based on Agrosalud80 for Latin America and the Carribean, and HarvestPlus74 for Asia and 
Africa, except for Golden Rice77 and Folate Biofortified Rice81. 
a The human body converts beta-carotene or provitamin A into vitamin A;  
b Niancin or Vitamin B3 is an essential nutrient which is mainly lacking in maize consuming populations82. Niancin is 
available in different foods, but can also be made in the human body through tryptophan, i.e. an amino acid that is 
improved by biofortification;  
c These are the selected countries where the biofortified crops are released or expected to be tested and released. 
However, after the first release, these crops are intended to benefit also other countries characterized by similar 
micronutrient deficiencies;  
d Because these crops are still in a development phase, it is too early to select a target country and a release date. Here, 
China was selected due to its high folate deficiency prevalence rates, its recent approval of Bt rice and the potential 
high impact of the introduction of Folate Biofortified Rice14;  
e Although the transgenic Golden Rice was expected to be released in 201183, field tests and biosafety regulations are 
still ongoing in the Philippines. The GR trait was also bred into rice varieties in, for example, India, Vietnam, 
Bangladesh and Indonesia.  
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Table 5. Approved (non-commercialized) GM rice events. 
Event name  Developer (institute, 
country) 
GM traits Country  Type of approval (year) 
  Foodb Feedb Cultivationc 
7Crp#10 
 
National Institute of 
Agrobiological Sciences 
(Japan) 
Anti-allergy 
antibiotic 
resistance 
Japan 2007  2007d 
7Crp#242-95-7 National Institute of 
Agrobiological Sciences 
(Japan) 
Anti-allergy 
antibiotic 
resistance 
Japan   2007d 
BTShanyou 63 Huazhong Agricultural 
University (China) 
Insect 
resistance 
China 2009 2009 2009 
Huahui-1/TT51-1  Huazhong Agricultural 
University (China) 
Insect 
resistance 
China   2009 
LLRICE06a Bayer CropScience 
(Germany) 
Herbicide 
tolerance 
USA 2000 2000 1999 
LLRICE601a Bayer CropScience 
(Germany) 
Herbicide 
tolerance 
Colombia 
USA 
2008 
2008 
  
2006 
LLRICE62a Bayer CropScience 
(Germany) 
Herbicide 
tolerance 
Australia 
Canada 
Colombia 
Mexico 
New Zealand 
Russia 
South Africa 
USA 
2008 
2006 
2008 
2007 
2008 
2007 
2011 
2000 
 
2006 
 
 
 
 
2011 
2000 
 
 
 
 
 
 
 
1999 
Tarom molaii + 
cry1Ab 
Agricultural Biotech 
Research Institute (Iran) 
Insect 
resistance 
Iran 2004 2004 2004 
Source: ISAAA GM approval database (www.isaaa.org/gmapprovaldatabase/) 
a Liberty Link rice 
b direct use or additive 
c domestic or non-domestic use 
d limited cultivation with proper isolation 
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Table 6. GM rice events in the pipeline. 
Event name  
(product name) 
Developer (institute, 
country) 
GM traits Development stage 
  
LLRICE62(Liberty 
Link rice) 
Bayer (Germany) 
 
Insect resistance 
Herbicide tolerance 
commercial pipeline 
Bt63 (MH63) China Insect resistance regulatory pipeline 
Xa21 China Other regulatory pipeline 
KMD1 China Insect resistance regulatory pipeline 
B827 Iran Insect resistance regulatory pipeline 
GR1 (Golden Rice 1) IRRI (Philippines) Crop composition advanced development 
Bar68-1 China 
Insect resistance 
Herbicide tolerance 
advanced development 
 Bayer (Germany) 
Insect resistance 
Herbicide tolerance 
advanced development 
GR2 (Golden Rice 2) IRRI (Philippines) Crop composition advanced development 
Bt Indonesia Insect resistance advanced development 
CP iORF-IV India Virus resistance advanced development 
RTBV-ODs2  India Virus resistance advanced development 
 Bayer (Germany) Insect resistance advanced development 
chi11 tlp India Disease resistance advanced development 
Bt Pakistan Insect resistance advanced development 
cry1Ac  India Insect resistance advanced development 
Glyoxalase I & II India Abiotic stress tolerance advanced development 
Osmotin India  Abiotic stress tolerance advanced development 
cry1Ab, cry1C & bar India  Insect resistance advanced development 
Source: Own compilation, based on Stein and Rodriguez86.  
Note: GM biofortified crops in bold. 
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Table 7.Characteristics of GM biofortified rice, per product and impact scenario 
 
 Folateb 
(Folate Biofortified Rice) 
Provitamin Ac 
(Golden Rice) 
 
Indicator Pessimistic 
scenario 
Optimistic  
scenario 
Pessimistic 
scenario 
Optimistic  
scenario 
Rice characteristics      
Initial micronutrient contenta µg per g rice 0.08 0 
GM rice characteristics      
Improved micronutrient content µg per g rice 12 20 30 
Post-harvest losses (e.g. cooking) % 75 50 80 20 
Bioavailability % 50d 50d 4:1e 2.3:1e 
Added micronutrient content  µg per g rice 1.4 2.9 1.0 6.5 
Total micronutrient content µg per g rice 1.5 3.0 1.0 6.5 
RNI, per key beneficiary       
Women of cba  µg 400f  
Children < 5 years  µg  500g 
Pregnant women  µg  800g 
Required rice consumption  
to achieve the RNI 
  
If current micronutrient intake = 0    
Without biofortification  g rice 5000.0 NAh 
With biofortification    
Women of cba  g rice 281.7 137.0   
Children < 5 years  g rice   500 76.7 
Pregnant women  g rice   800 122.7 
cba, childbearing age; NA, not applicable; RNI, recommended nutrient intake  
Source: unless noted otherwise, based on De Steur et al.26 
a USDA103 
b Storozhenko et al.81 and De Steur et al.27 
cZimmerman and Qaim104, and Stein et al.105, updated by Golden Rice Project experts 
d Bailey106 
e Bioconversion factors refer to the bioavailability of provitamin A and the conversion to vitamin A. Based on Tang et 
al.107, updated by Golden Rice Project experts 
f WHO108. The target group of Folate Biofortified Rice consumption is women of childbearing age, as the health 
benefits  refer to newborns. 
g IOM109(children) and FAO/WHO110 (pregnant women) 
hAs the initial provitamin A content of rice is nonexistent, one could not consume provitamin A through regular rice 
consumption. 
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Table 8. Willingness-to-pay for GM biofortified rice, main characteristics per study 
Study Trait  Publication 
year 
Methodology Country % premium  
(WTP) 
Li et al.112 Vitaminsa 2002 DC contingent 
valuation 
Urban China 38.0 
De Steur et al.113 Folate 2010 OE contingent 
valuation 
Rural China 71.7 
De Steur et al.114 Folate 2012 Experimental 
auction 
Rural China 33.7 
Deodhar et al.115 Provitamin A 2008 DC contingent 
valuation 
India  19.5 
Depositario et al.116, Provitamin A 2009 Experimental 
auction 
Philippines 40.0 
Lusk et al.117 Provitamin A 2003 DC contingent 
valuation 
United States 16.0 
DC, dichotomous choice; ND, no data; OE, open-ended 
Note: In golden rice, provitamin A or beta-carotene levels are elevated in order to increase vitamin A consumption. 
a Valuations refer to rice with enhanced vitamin levels in general (without specification of the particular vitamin trait) 
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Table 9. Potential health impacts and cost-effectiveness of GM biofortified rice, main characteristics per 
study  
 
Trait Country 
Health impact Cost-effectiveness  
Study Pessimistic Optimistic Pessimistic Optimistic 
   % burden reduction US$/DALY saved 
De Steur et al.26 Folate Shanxi Provinceb 20 60 120.3 40.1 
De Steur et al.25  China 20 60 64.2 21.4 
De Steur et al.26 Provitamin A  China 17 60 18.1 5.0 
Stein et al.105  India 9 59 23.2 3.7 
Zimmerman & Qaim104  Philippines 6 32          / / 
De Steur et al.26 Multi (GM)a China 11 46 9.6 2.3 
DALYs, Disability-Adjusted Life Years; GM, genetically modified; WB, World Bank 
Note: All cost-effectiveness figures are expressed in 2011 dollars, based on BLS inflation calculator123 
a Multi-biofortified rice contains higher folate, provitamin A, zinc and iron levels;  
b Rural province in Northern China 
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Figures 
 
Figure 1. Number of articles on GM food, GM rice, biofortification and Golden Rice, as derived from the 
Web of Knowledge literature database (2000-2011) 
 
Source: own compilation, based on Web of Knowledge (2011).  
Note: Recent figures (2012) were not included as they were incomplete at the time of the study.  
 
